The DOI matches its Crossref record; 155 of the 156 references it cites were found in a registry or an index.
Fatty Acid Amide Hydrolase: A Gate-Keeper of the Endocannabinoid System
Abstract
The family of endocannabinoids contains several polyunsaturated fatty acid amides such as anandamide (AEA), but also esters such as 2-arachidonoylglycerol (2-AG). These compounds are the main endogenous agonists of cannabinoid receptors, able to mimic several pharmacological effects of Delta9-tetrahydrocannabinol (Delta9-THC), the active principle of Cannabis sativa preparations like hashish and marijuana. The activity of AEA at its receptors is limited by cellular uptake, through a putative membrane transporter, followed by intracellular degradation by fatty acid amide hydrolase (FAAH). Growing evidence demonstrates that FAAH is the critical regulator of the endogenous levels of AEA, suggesting that it may serve as an attractive therapeutic target for the treatment of human disorders. In particular, FAAH inhibitors may be next generation therapeutics of potential value for the treatment of pathologies of the central nervous system, and of peripheral tissues. Investigations into the structure and function of FAAH, its biological and therapeutic implications, as well as a description of different families of FAAH inhibitors, are the topic of this chapter.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Besides serving as the major catabolic enzyme of AEA, FAAH hydrolyzes other bioactive lipids, such as N-palmitoylethanolamine (PEA) (Fezza et al, 2008), which does not bind cannabinoid receptors, but functions as an endogenous ligand for peroxisome proliferator receptor-α (PPAR-α) (Lo Verme et al, 2005).”
From The endogenous cannabinoid system: a budding source of targets for treating inflammatory and neuropathic pain (2018) · cites this paper as Fezza et al, 2008
In the citing paper
“Fatty-acid amide hydrolase (FAAH) is the principle catabolic enzyme for fatty-acid amides including AEA and N-palmitoylethanolamine (PEA).25”
From Cannabinoids as Pharmacotherapies for Neuropathic Pain: From the Bench to the Bedside (2009) · cites this paper as [25]
Citations
Cites
International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels
Catterall, W. A., Chandy, K. G., Clapham, D. E., Gutman, G. A., Hofmann, F., Harmar, A. J., Abernethy, D. R., & Spedding, M. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.4.5 · Cited by 7,126
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
Molecular characterization of a peripheral receptor for cannabinoids
Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092
Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00109-d · Cited by 2,913
International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors
Howlett, A. C., Barth, F., Bonner, T. I., Cabral, G., Casellas, P., Devane, W. A., Felder, C. C., Herkenham, M., Mackie, K., Martin, B. R., et al. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.161 · Cited by 2,819
Determination and characterization of a cannabinoid receptor in rat brain
Devane, W. A., Dysarz, F. A., Johnson, M. R., Melvin, L. S., & Howlett, A. C. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09876-1 · Cited by 2,443 · cited 12×
“AEA and 2-AG are present in the central nervous system (CNS) and also in peripheral tissues (Sugiura et al., 2002), but exhibit important differences in their quantitative distribution; 2-AG is more abundant than AEA in the brain and behaves as a full agonist for CB1R and CB2R, while AEA acts as partial agonist for CB…”
BackgroundInfluential2-Arachidonoylgylcerol: A Possible Endogenous Cannabinoid Receptor Ligand in Brain
Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., Yamashita, A., & Waku, K. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2437 · Cited by 2,196
Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides
Cravatt, B. F., Giang, D. K., Mayfield, S. P., Boger, D. L., Lerner, R. A., & Gilula, N. B. (1996) · Nature · doi:10.1038/384083a0 · Cited by 2,125
The molecular logic of endocannabinoid signalling
Piomelli, D. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1247 · Cited by 1,957
Formation and inactivation of endogenous cannabinoid anandamide in central neurons
Marzo, V. D., Fontana, A., Cadas, H., Schinelli, S., Cimino, G., Schwartz, J.-C., & Piomelli, D. (1994) · Nature · doi:10.1038/372686a0 · Cited by 1,585
The orphan receptor GPR55 is a novel cannabinoid receptor
Ryberg, E., Larsson, N., Sjögren, S., Hjorth, S., Hermansson, N., Leonova, J., Elebring, T., Nilsson, K., Drmota, T., & Greasley, P. J. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707460 · Cited by 1,568
A second endogenous cannabinoid that modulates long-term potentiation
Stella, N., Schweitzer, P., & Piomelli, D. (1997) · Nature · doi:10.1038/42015 · Cited by 1,496
Identification and Functional Characterization of Brainstem Cannabinoid CB2Receptors
Van Sickle, M. D., Duncan, M., Kingsley, P. J., Mouihate, A., Urbani, P., Mackie, K., Stella, N., Makriyannis, A., Piomelli, D., Davison, J. S., et al. (2005) · Science · doi:10.1126/science.1115740 · Cited by 1,470
Brain monoglyceride lipase participating in endocannabinoid inactivation
Dinh, T. P., Carpenter, D., Leslie, F. M., Freund, T. F., Katona, I., Sensi, S. L., Kathuria, S., & Piomelli, D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.152334899 · Cited by 1,373
Bisogno, T., Hanuš, L., PETROCELLIS, L. D., Tchilibon, S., Ponde, D. E., Brandi, I., Moriello, A. S., Davis, J. B., Mechoulam, R., & Marzo, V. D. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704327 · Cited by 1,315
Modulation of anxiety through blockade of anandamide hydrolysis
Kathuria, S., Gaetani, S., Fegley, D., Valiño, F., Duranti, A., Tontini, A., Mor, M., Tarzia, G., Rana, G. L., Calignano, A., et al. (2003) · Nature Medicine · doi:10.1038/nm803 · Cited by 1,293
The X-ray crystal structure of the membrane protein prostaglandin H2 synthase-1
Picot, D., Loll, P. J., & Garavito, R. M. (1994) · Nature · doi:10.1038/367243a0 · Cited by 1,270
Bisogno, T., Howell, F., Williams, G., Minassi, A., Cascio, M. G., Ligresti, A., Matias, I., Schiano-Moriello, A., Paul, P., Williams, E.-J., et al. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200305129 · Cited by 1,039
Molecular Basis for Species-Specific Sensitivity to “Hot” Chili Peppers
Jordt, S., & Julius, D. J. (2002) · Cell · doi:10.1016/s0092-8674(02)00637-2 · Cited by 881
Molecular Characterization of a Phospholipase D Generating Anandamide and Its Congeners
Okamoto, Y., Morishita, J., Tsuboi, K., Tonai, T., & Ueda, N. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306642200 · Cited by 800
2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB 1 receptor
Hanuš, L., Abu‐Lafi, S., Fride, E., Breuer, A., Vogel, Z., Shalev, D. E., Kustanovich, I. M., & Mechoulam, R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.061029898 · Cited by 761
Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist
Deutsch, D. G., & Chin, S. A. (1993) · Biochemical Pharmacology · doi:10.1016/0006-2952(93)90486-g · Cited by 706
Structure and function of fatty acid amide hydrolase
McKinney, M. K., & Cravatt, B. F. (2005) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.74.082803.133450 · Cited by 680
Ben‐Shabat, S., Fride, E., Sheskin, T., Tamiri, T., Rhee, M. H., Vogel, Z., Bisogno, T., PETROCELLIS, L. D., Marzo, V. D., & Mechoulam, R. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00392-6 · Cited by 650
Benito, C., Núñez, E., Tolón, R. M., Carrier, E. J., Rábano, A., Hillard, C. J., & Romero, J. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-35-11136.2003 · Cited by 636
Porter, A. C., Sauer, J., Knierman, M. D., Becker, G. W., Berna, M. J., Bao, J., Nomikos, G. G., Carter, P. A., Bymaster, F. P., Leese, A. B., et al. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.3.1020 · Cited by 614
Cannabis: pharmacology and toxicology in animals and humans
Adams, I. B., & Martin, B. R. (1996) · Addiction · doi:10.1046/j.1360-0443.1996.911115852.x · Cited by 576
Gulyas, A. I., Cravatt, B. F., Bracey, M. H., Dinh, T. P., Piomelli, D., Boscia, F., & Freund, T. F. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03428.x · Cited by 561
Structural Adaptations in a Membrane Enzyme That Terminates Endocannabinoid Signaling
Bracey, M. H., Hanson, M. A., Masuda, K. R., Stevens, R. C., & Cravatt, B. F. (2002) · Science · doi:10.1126/science.1076535 · Cited by 490
A biosynthetic pathway for anandamide
Liu, J., Wang, L., Harvey-White, J. D., Osei‐Hyiaman, D., Razdan, R. J., Gong, Q., Chan, A. C., Zhou, Z., Huang, B. X., Kim, H., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601832103 · Cited by 481
The endocannabinoid system: a general view and latest additions
PETROCELLIS, L. D., Cascio, M. G., & Marzo, V. D. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705666 · Cited by 473
Structure and Function of a Squalene Cyclase
Wendt, K. U., Poralla, K., & Schulz, G. E. (1997) · Science · doi:10.1126/science.277.5333.1811 · Cited by 457
Pharmacological Profile of the Selective FAAH Inhibitor KDS-4103 (URB597)
Piomelli, D., Tarzia, G., Duranti, A., Tontini, A., Mor, M., Compton, T. R., Dasse, O. A., Monaghan, E. P., Parrott, J. A., & Putman, D. (2006) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2006.00021.x · Cited by 451
Molecular characterization of human and mouse fatty acid amide hydrolases
Giang, D. K., & Cravatt, B. F. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2238 · Cited by 429
The endocannabinoid system as a target for therapeutic drugs
Piomelli, D., Giuffrida, A., Calignano, A., & Rodrı́guez de Fonseca, F. (2000) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01482-6 · Cited by 421
Genome-wide expression profiling of human blood reveals biomarkers for Huntington's disease
Borovečki, F., Lovrečić, L., Zhou, J., Jeong, H., Then, F., Rosas, H. D., Hersch, S. M., Hogarth, P., Bouzou, B., Jensen, R. V., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504921102 · Cited by 417
van der Stelt, M., & Marzo, V. D. (2004) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.2004.04081.x · Cited by 388
Biochemistry and pharmacology of endovanilloids
Starowicz, K., Nigam, S., & Marzo, V. D. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.01.005 · Cited by 381
Sawzdargo, M., Nguyen, T., Lee, D. K., Lynch, K. R., Cheng, R., Heng, H. H., George, S. R., & O’Dowd, B. F. (1999) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00277-0 · Cited by 378
Howlett, A. C., & Fleming, R. M. (1984) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)15066-9 · Cited by 376
Sugiura, T., Kondo, S., Kishimoto, S., Miyashita, T., Nakane, S., Kodaka, T., Suhara, Y., Takayama, H., & Waku, K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.1.605 · Cited by 373
A Second Fatty Acid Amide Hydrolase with Variable Distribution among Placental Mammals
Wei, B. Q., Mikkelsen, T. S., McKinney, M. K., Lander, E. S., & Cravatt, B. F. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m606646200 · Cited by 368
Spider toxins activate the capsaicin receptor to produce inflammatory pain
Siemens, J., Zhou, S., Piskorowski, R. A., Nikai, T., Lumpkin, E. A., Basbaum, A. I., King, D., & Julius, D. J. (2006) · Nature · doi:10.1038/nature05285 · Cited by 368
Simon, G. M., & Cravatt, B. F. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604660200 · Cited by 360
A missense mutation in human fatty acid amide hydrolase associated with problem drug use
Sipe, J. C., Chiang, K. P., Gerber, A. L., Beutler, E., & Cravatt, B. F. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.082235799 · Cited by 354
Leung, D., Saghatelian, A., Simon, G. M., & Cravatt, B. F. (2006) · Biochemistry · doi:10.1021/bi060163l · Cited by 354
Sugiura, T., Kobayashi, Y., Oka, S., & Waku, K. (2002) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2001.0356 · Cited by 351
Lauckner, J. E., Hille, B., & Mackie, K. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509588102 · Cited by 348
In silico patent searching reveals a new cannabinoid receptor
Baker, D., Pryce, G., Davies, W. I. L., & Hiley, C. R. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.11.003 · Cited by 347
Huang, S. M., Bisogno, T., Petros, T. J., Chang, S. Y., Zavitsanos, P. A., Zipkin, R. E., Sivakumar, R., Coop, A., Maeda, D. Y., PETROCELLIS, L. D., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107351200 · Cited by 339
Anandamide Amidohydrolase Activity in Rat Brain Microsomes
Desarnaud, F., Cadas, H., & Piomelli, D. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.11.6030 · Cited by 336
Lichtman, A. H., Leung, D., Shelton, C. C., Saghatelian, A., Hardouin, C., Boger, D. L., & Cravatt, B. F. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.069401 · Cited by 332
Tsuboi, K., Sun, Y.-X., Okamoto, Y., Araki, N., Tonai, T., & Ueda, N. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413473200 · Cited by 330
Felder, C. C., Nielsen, A., Briley, E. M., Palkovits, M., Priller, J., Axelrod, J., Nguyen, D. N., Richardson, J. M., Riggin, R. M., KOPPEL, G. A., et al. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)00891-5 · Cited by 328
Gubellini, P., Picconi, B., Bari, M., Battista, N., Calabresi, P., Centonze, D., Bernardi, G., Finazzi‐Agrò, A., & Maccarrone, M. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-16-06900.2002 · Cited by 321
Self-citationBisogno, T., Berrendero, F., Ambrosino, G., Cebeira, M., Ramos, J. A., Fernández‐Ruíz, J., & Marzo, V. D. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0254 · Cited by 313
Fatty acid amide hydrolase: an emerging therapeutic target in the endocannabinoid system
Cravatt, B. F., & Lichtman, A. H. (2003) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(03)00079-6 · Cited by 303
Ueda, N., Kurahashi, Y., Yamamoto, S., & Tokunaga, T. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.40.23823 · Cited by 303
Marzo, V. D., Hill, M. P., Bisogno, T., Crossman, A. R., & Brotchie, J. M. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.10.1432 · Cited by 303
Marzo, V. D., Bisogno, T., PETROCELLIS, L. D., Melck, D. J., Orlando, P., Wagner, J. A., & Kunos, G. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00631.x · Cited by 296
Caillé, S., Alvarez-Jaimes, L., Polis, I., Stouffer, D. G., & Parsons, L. H. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4403-06.2007 · Cited by 280
Evidence against the presence of an anandamide transporter
Glaser, S. T., Abumrad, N. A., Fatade, F., Kaczocha, M., Studholme, K. M., & Deutsch, D. G. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0730816100 · Cited by 280
Capsaicin Binds to the Intracellular Domain of the Capsaicin-Activated Ion Channel
Jung, J., Hwang, S. W., Kwak, J., Lee, S.-Y., Kang, C.-J., Kim, W. B., Kim, D., & Oh, U. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-02-00529.1999 · Cited by 278
Chiang, K. P. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh216 · Cited by 278
Mor, M., Rivara, S., Lodola, A., Plazzi, P. V., Tarzia, G., Duranti, A., Tontini, A., Piersanti, G., Kathuria, S., & Piomelli, D. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm031140x · Cited by 277
Boger, D. L., Sato, H., Lerner, A. E., Hedrick, M. P., Fecik, R. A., Miyauchi, H., Wilkie, G. D., Austin, B. J., Patricelli, M. P., & Cravatt, B. F. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.10.5044 · Cited by 272
Overweight and obesity associated with a missense polymorphism in fatty acid amide hydrolase (FAAH)
Sipe, J. C., Waalen, J., Gerber, A., & Beutler, E. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0802954 · Cited by 266
Relation between decreased anandamide hydrolase concentrations in human lymphocytes and miscarriage
Maccarrone, M., Valensise, H. C. C., Bari, M., Lazzarin, N., Romaninï, C., & Finazzi‐Agrò, A. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02115-2 · Cited by 240
Self-citationYong-Xin, S. U. N., Tsuboi, K., Okamoto, Y., Tonai, T., Murakami, M., Kudo, I., & Ueda, N. (2004) · Biochemical Journal · doi:10.1042/bj20040031 · Cited by 236
2-Arachidonoylglycerol and the cannabinoid receptors
Sugiura, T., & Waku, K. (2000) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(00)00189-4 · Cited by 236
Dinh, T. P., Kathuria, S., & Piomelli, D. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.002071 · Cited by 234
Beltramo, M., & Piomelli, D. (2000) · Neuroreport · doi:10.1097/00001756-200004270-00018 · Cited by 230
Fegley, D., Kathuria, S., Mercier, R., Li, C., Goutopoulos, A., Makriyannis, A., & Piomelli, D. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400997101 · Cited by 230
Cannabinoids and brain injury: therapeutic implications
Mechoulam, R. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02276-1 · Cited by 229
Alexander, J. P., & Cravatt, B. F. (2005) · Chemistry & Biology · doi:10.1016/j.chembiol.2005.08.011 · Cited by 227
Lichtman, A. H., Hawkins, E. G., Griffin, G., & Cravatt, B. F. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.302.1.73 · Cited by 224
Marzo, V. D. (2000) · The FASEB Journal · doi:10.1096/fj.14.10.1432 · Cited by 219
Boger, D. L., Miyauchi, H., Du, W., Hardouin, C., Fecik, R. A., Cheng, H. W., Hwang, I., Hedrick, M. P., Leung, D., Acevedo, O., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049614v · Cited by 218
Methyl arachidonyl fluorophosphonate: a potent irreversible inhibitor of anandamide amidase
Deutsch, D. G., Omeir, R. L., Arreaza, G., Salehani, D., Prestwich, G. D., Huang, Z., & Howlett, A. C. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(96)00830-1 · Cited by 217
Novel Mechanistic Class of Fatty Acid Amide Hydrolase Inhibitors with Remarkable Selectivity
Ahn, K., Johnson, D. S., Fitzgerald, L. R., Liimatta, M. B., Arendse, A., Stevenson, T. I., Lund, E. T., Nugent, R. A., Nomanbhoy, T. K., Alexander, J. P., et al. (2007) · Biochemistry · doi:10.1021/bi701378g · Cited by 217
Goparaju, S. K., Ueda, N., Taniguchi, K., & Yamamoto, S. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00314-1 · Cited by 212
Lipid Rafts Control Signaling of Type-1 Cannabinoid Receptors in Neuronal Cells
Bari, M., Battista, N., Fezza, F., Finazzi‐Agrò, A., & Maccarrone, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411642200 · Cited by 210
Self-citationCentonze, D., Bari, M., Rossi, S., Prosperetti, C., Furlan, R., Fezza, F., De Chiara, V., Battistini, L., Bernardi, G., Bernardini, S., et al. (2007) · Brain · doi:10.1093/brain/awm160 · Cited by 207
Self-citationMaurelli, S., Bisogno, T., PETROCELLIS, L. D., Luccia, A. D., Marino, G., & Marzo, V. D. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)01311-3 · Cited by 200
Anandamide Hydrolysis by Human Cells in Culture and Brain
Maccarrone, M., van der Stelt, M., Rossi, A., Veldink, G. A., Vliegenthart, J. F. G., & Finazzi‐Agrò, A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.48.32332 · Cited by 196
Self-citationThe endocannabinoid system in targeting inflammatory neurodegenerative diseases
Centonze, D., Finazzi‐Agrò, A., Bernardi, G., & Maccarrone, M. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.02.004 · Cited by 182
Self-citationEvolutionary origins of the endocannabinoid system
McPartland, J. M., Matias, I., Marzo, V. D., & Glass, M. (2006) · Gene · doi:10.1016/j.gene.2005.11.004 · Cited by 176
Identification of a Novel Endocannabinoid-Hydrolyzing Enzyme Expressed by Microglial Cells
Muccioli, G. G., Xu, C., Odah, E., Cudaback, E., Cisneros, J. A., Lambert, D. M., López-Rodríguez, M. L., Bajjalieh, S., & Stella, N. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.4830-06.2007 · Cited by 175
Dewey, W. L. (1986) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06864-4 · Cited by 166
Bisogno, T., Melck, D. J., PETROCELLIS, L. D., & Marzo, V. D. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0722113.x · Cited by 162
The uptake by cells of 2‐arachidonoylglycerol, an endogenous agonist of cannabinoid receptors
Bisogno, T., Maccarrone, M., PETROCELLIS, L. D., Jarrahian, A., Finazzi‐Agrò, A., Hillard, C. J., & Marzo, V. D. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.02072.x · Cited by 160
Self-citationEndogenous Cannabinoid Signaling
Piomelli, D., Beltramo, M., Giuffrida, A., & Stella, N. (1998) · Neurobiology of Disease · doi:10.1006/nbdi.1998.0221 · Cited by 160
Fatty acid amide hydrolase deficiency limits early pregnancy events
Wang, H. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28621 · Cited by 160
The Volatile Oil Composition of Fresh and Air-Dried Buds of Cannabis sativa
Ross, S. A., & ElSohly, M. A. (1996) · Journal of Natural Products · doi:10.1021/np960004a · Cited by 158
Maccarrone, M., Valensise, H. C. C., Bari, M., Lazzarin, N., Romaninï, C., & Finazzi‐Agrò, A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.12.7183 · Cited by 152
Self-citationvan der Stelt, M., van Kuik, J. A., Bari, M., van Zadelhoff, G., Leeflang, B. R., Veldink, G. A., Finazzi‐Agrò, A., Vliegenthart, J. F. G., & Maccarrone, M. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020818q · Cited by 152
Self-citationPatricelli, M. P., Lovato, M. A., & Cravatt, B. F. (1999) · Biochemistry · doi:10.1021/bi990637z · Cited by 152
Further evidence for the existence of a specific process for the membrane transport of anandamide
Ligresti, A., Morera, E., van der Stelt, M., Monory, K., Lutz, B., Ortar, G., & Marzo, V. D. (2004) · Biochemical Journal · doi:10.1042/bj20031812 · Cited by 149
Novel selective and metabolically stable inhibitors of anandamide cellular uptake
Ortar, G., Ligresti, A., PETROCELLIS, L. D., Morera, E., & Marzo, V. D. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00109-6 · Cited by 149
Patricelli, M. P., Lashuel, H. A., Giang, D. K., Kelly, J. W., & Cravatt, B. F. (1998) · Biochemistry · doi:10.1021/bi981733n · Cited by 147
Paria, B. C., Deutsch, D. D., & Dey, S. K. (1996) · Molecular Reproduction and Development · doi:10.1002/(sici)1098-2795(199610)45:2 · Cited by 142
Cannabinoids Induce Glioma Stem-like Cell Differentiation and Inhibit Gliomagenesis
Aguado, T., Carracedo, A., Julien, B., Velasco, G., Milman, G., Mechoulam, R., Álvarez, L., Guzmán, M., & Galve‐Roperh, I. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608900200 · Cited by 140
Study of the amidase signature group
Chebrou, H., Bigey, F., Arnaud, A., & Galzy, P. (1996) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/s0167-4838(96)00145-8 · Cited by 139
A Role for Caveolae/Lipid Rafts in the Uptake and Recycling of the Endogenous Cannabinoid Anandamide
McFarland, M. J., Porter, A. C., Rakhshan, F., Rawat, D. S., Gibbs, R. A., & Barker, E. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407250200 · Cited by 139
Role of Fatty Acid Amide Hydrolase in the Transport of the Endogenous Cannabinoid Anandamide
Day, T. A., Rakhshan, F., Deutsch, D. G., & Barker, E. L. (2001) · Molecular Pharmacology · doi:10.1124/mol.59.6.1369 · Cited by 139
Patricelli, M. P., & Cravatt, B. F. (1999) · Biochemistry · doi:10.1021/bi991876p · Cited by 135
Fatty Acid Sulfonyl Fluorides Inhibit Anandamide Metabolism and Bind to the Cannabinoid Receptor
Deutsch, D. G., Lin, S., Hill, W. A. G., Morse, K. L., Salehani, D., Arreaza, G., Omeir, R. L., & Makriyannis, A. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6072 · Cited by 134
Biochemistry of the Endogenous Ligands of Cannabinoid Receptors
Marzo, V. D., & Deutsch, D. G. (1998) · Neurobiology of Disease · doi:10.1006/nbdi.1998.0214 · Cited by 133
Prostaglandin Ethanolamides (Prostamides): In Vitro Pharmacology and Metabolism
Matias, I., Chen, J., PETROCELLIS, L. D., Bisogno, T., Ligresti, A., Fezza, F., Krauss, A. H. ‐., Shi, L., Protzman, C. E., Li, C., et al. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.061705 · Cited by 129
Self-citationShin, S., Lee, T., Ha, N., Koo, H. M., Kim, S., Lee, H., Kim, Y. S., & Oh, B. (2002) · The EMBO Journal · doi:10.1093/emboj/21.11.2509 · Cited by 127
Down-regulation of anandamide hydrolase in mouse uterus by sex hormones
Maccarrone, M., Felici, M. D., Bari, M., Klinger, F. G., Siracusa, G., & Finazzi‐Agrò, A. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2000.01316.x · Cited by 124
Self-citationGuo, Y. X., Wang, H., Okamoto, Y., Ueda, N., Kingsley, P. J., Marnett, L. J., Schmid, H. H. O., Das, S., & Dey, S. K. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c500168200 · Cited by 123
Park, B., Gibbons, H. M., Mitchell, M. D., & Glassa, M. (2003) · Placenta · doi:10.1053/plac.2002.0926 · Cited by 122
The enzymatic inactivation of the fatty acid amide class of signaling lipids
Cravatt, B. F., & Lichtman, A. H. (2002) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(02)00147-0 · Cited by 118
Novel Inhibitors of Brain, Neuronal, and Basophilic Anandamide Amidohydrolase
PETROCELLIS, L. D., Melck, D. J., Ueda, N., Maurelli, S., Kurahashi, Y., Yamamoto, S., Marino, G., & Marzo, V. D. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6000 · Cited by 117
Maccarrone, M., Bari, M., Rienzo, M. D., Finazzi‐Agrò, A., & Rossi, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302123200 · Cited by 110
Self-citationAnandamide hydrolysis: a new target for anti-anxiety drugs?
Gaetani, S., Cuomo, V., & Piomelli, D. (2003) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2003.09.005 · Cited by 104
Transcriptional regulation of the mouse fatty acid amide hydrolase gene
Waleh, N. S., Cravatt, B. F., Apte-Deshpande, A. D., Terao, A., & Kilduff, T. S. (2002) · Gene · doi:10.1016/s0378-1119(02)00598-x · Cited by 100
An Alternative Mechanism for Amidase Signature Enzymes
Labahn, J., Neumann, S., Büldt, G., Kula, M., & Granzin, J. (2002) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)00886-0 · Cited by 98
Oka, S., Tsuchie, A., Tokumura, A., Muramatsu, M., Suhara, Y., Takayama, H., Waku, K., & Sugiura, T. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01804.x · Cited by 96
Rossi, C., Pini, L. A., Cupini, M. L., Calabresi, P., & Sarchielli, P. (2007) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-007-0391-4 · Cited by 93
Fersht, A. R. (1971) · Journal of the American Chemical Society · doi:10.1021/ja00743a035 · Cited by 91
Park, B., Gibbons, H. M., Mitchell, M. D., & Glass, M. (2003) · Placenta · doi:10.1016/s0143-4004(03)00165-6 · Cited by 90
Boger, D. L., Miyauchi, H., & Hedrick, M. P. (2001) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)00211-6 · Cited by 89
Leptin Activates the Anandamide Hydrolase Promoter in Human T Lymphocytes through STAT3
Maccarrone, M., Rienzo, M. D., Finazzi‐Agrò, A., & Rossi, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211248200 · Cited by 87
Self-citationIdentification and Partial Characterization
Wintroub, B. U., Kaempfer, C. E., Schechter, N. M., & Proud, D. (1986) · Cited by 85
Transcriptional regulation of the cannabinoid receptor type 1 gene in T cells by cannabinoids
Börner, C., Höllt, V., Sebald, W., & Kraus, J. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.0306224 · Cited by 80
Plant-derived, synthetic and endogenous cannabinoids as neuroprotective agents
Fowler, C. J. (2003) · Brain Research Reviews · doi:10.1016/s0165-0173(02)00218-7 · Cited by 76
Cupini, L., Bari, M., Battista, N., Argirò, G., Finazzi‐Agrò, A., Calabresi, P., & Maccarrone, M. (2005) · Cephalalgia · doi:10.1111/j.1468-2982.2005.01031.x · Cited by 74
Self-citationLópez-Rodríguez, M. L., Viso, A., Ortega‐Gutiérrez, S., Lastres‐Becker, I., González, S. R., Fernández‐Ruíz, J., & Ramos, J. A. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm015545y · Cited by 70
Targeting the CB2receptor for immune modulation
Lunn, C. A., Reich, E., & Bober, L. A. (2006) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.10.5.653 · Cited by 68
Regulation of anandamide tissue levels by N-arachidonylglycine
BURSTEIN, S. H., Huang, S. M., Petros, T. J., Rossetti, R. G., Walker, J. M., & Zurier, R. B. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01301-1 · Cited by 67
Tarzia, G., Duranti, A., Gatti, G., Piersanti, G., Tontini, A., Rivara, S., Lodola, A., Plazzi, P. V., Mor, M., Kathuria, S., et al. (2005) · ChemMedChem · doi:10.1002/cmdc.200500017 · Cited by 62
Yang, H.-Y. T., Karoum, F., Felder, C. C., Badger, H., Wang, T.-C. L., & Markey, S. P. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0721959.x · Cited by 61
Battista, N., Bari, M., Tarditi, A., Mariotti, C., Bachoud‐Lévi, A., Zuccato, C., Finazzi‐Agrò, A., Genitrini, S., Peschanski, M., Donato, S. D., et al. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.04.012 · Cited by 60
Self-citationOddi, S., Bari, M., Battista, N., Barsacchi, D., Cozzani, I., & Maccarrone, M. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4446-8 · Cited by 60
Self-citationAberle, J., Fedderwitz, I., Klages, N., George, E., & Beil, F. U. (2007) · Hormone and Metabolic Research · doi:10.1055/s-2007-977694 · Cited by 58
Paria, B. C., Zhao, X., Wang, J., Das, S., & Dey, S. K. (1999) · Biology of Reproduction · doi:10.1095/biolreprod60.5.1151 · Cited by 55
Anandamide hydrolase: a guardian angel of human reproduction?
Maccarrone, M., & Finazzi‐Agrò, A. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.05.002 · Cited by 53
Self-citationEdwards, P. D., Zottola, M. A., Davis, M. W., Williams, J. C., & Tuthill, P. A. (1995) · Journal of Medicinal Chemistry · doi:10.1021/jm00020a011 · Cited by 51
Goparaju, S. K., Kurahashi, Y., Suzuki, H., Ueda, N., & Yamamoto, S. (1999) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(99)00143-2 · Cited by 50
Fatty Acid Amide Hydrolase: A Potential Target for Next Generation Therapeutics
Maccarrone, M. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206775474279 · Cited by 48
Self-citationVandevoorde, S., Saha, B., Mahadevan, A., Razdan, R. K., Pertwee, R. G., Martin, B. R., & Fowler, C. J. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.09.015 · Cited by 46
Structural commonalities among integral membrane enzymes
Bracey, M. H., Cravatt, B. F., & Stevens, R. C. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.04.084 · Cited by 46
Cannabinoid Properties of Methylfluorophosphonate Analogs
Martin, B. R., Beletskaya, I., Patrick, G., Jefferson, R. G., Winckler, R., Deutsch, D. G., Marzo, V. D., Dasse, O. A., Mahadevan, A., & Razdan, R. K. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39191-8 · Cited by 46
Edgemond, W. S., Greenberg, M. J., McGinley, P. J., Muthian, S., Campbell, W. B., & Hillard, C. J. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37574-3 · Cited by 44
Abnormal Gene Product Identified in Huntington′s Disease Lymphocytes and Brain
Ide, K., Nukina, N., Masuda, N., Goto, J., & Kanazawa, I. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.1613 · Cited by 43
Deletion of a proline‐rich region and a transmembrane domain in fatty acid amide hydrolase1
Arreaza, G., & Deutsch, D. G. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00774-7 · Cited by 31
Wan, M., Cravatt, B. F., Ring, H. Z., Zhang, X., & Francke, U. (1998) · Genomics · doi:10.1006/geno.1998.5597 · Cited by 31
Segall, Y., Quistad, G. B., Nomura, D. K., & Casida, J. E. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00721-2 · Cited by 26
Maccarrone, M., Gasperi, V., Fezza, F., Finazzi‐Agrò, A., & Rossi, A. (2004) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.2004.04427.x · Cited by 24
Self-citationGenetic Polymorphisms of the Endocannabinoid System
Norrod, A. G., & Puffenbarger, R. A. (2007) · Chemistry & Biodiversity · doi:10.1002/cbdv.200790160 · Cited by 22
Characterization of the 5′-sequence of the mouse fatty acid amide hydrolase
Puffenbarger, R. A., Kapulina, O., Howell, J. M., & Deutsch, D. G. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)02274-1 · Cited by 21
Closing the Gate to the Active Site
Mei, G., Venere, A. D., Gasperi, V., Nicolai, E., Masuda, K. R., Finazzi‐Agrò, A., Cravatt, B. F., & Maccarrone, M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605653200 · Cited by 14
Self-citationCuthbert, A. W. (1979) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(79)90002-6 · Cited by 12
Cited by
Sorted by citations
Is lipid signaling through cannabinoid 2 receptors part of a protective system?
Pacher, P., & Mechoulam, R. (2011) · Progress in Lipid Research · doi:10.1016/j.plipres.2011.01.001 · Cited by 435
Modulating the endocannabinoid system in human health and disease – successes and failures
Pacher, P., & Kunos, G. (2013) · FEBS Journal · doi:10.1111/febs.12260 · Cited by 418
Marzo, V. D. (2009) · Pharmacological Research · doi:10.1016/j.phrs.2009.02.010 · Cited by 381
Cannabinoids as Pharmacotherapies for Neuropathic Pain: From the Bench to the Bedside
Rahn, E. J., & Hohmann, A. G. (2009) · Neurotherapeutics · doi:10.1016/j.nurt.2009.08.002 · Cited by 305
Donvito, G., Nass, S. R., Wilkerson, J. L., Curry, Z. A., Schurman, L. D., Kinsey, S. G., & Lichtman, A. H. (2018) · Neuropsychopharmacology · doi:10.1038/npp.2017.204 · Cited by 301
Metadata
- Authors
- Fezza, F., De Simone, C., Amadio, D., & Maccarrone, M.
- Affiliations
- University of Rome Tor Vergata (IT)
- Venue
- Subcellular Biochemistry
- Publisher
- Springer Netherlands
- Published
- 2008
- Volume
- 49
- Pages
- 101-132
- ISSN
- 0306-0225 (ISSN-L)
- OpenAlex
- W97923480
- Cited by
- 99
- References
- 156
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 1 · 2023: 1 · 2022: 3 · 2021: 3 · 2020: 5 · 2019: 2 · 2018: 3 · 2017: 5 · 2016: 9 · 2015: 7 · 2014: 8 · 2013: 7 · 2012: 8
- FWCI
- 44.84
- Type
- book chapter
- Language
- en
- Open access
- closed
- Locations
- Sub-cellular biochemistry/Subcellular biochemistry (publishedVersion)
- PubMed (publishedVersion)
- Archivio Istituzionale della Ricerca - Università degli Studi dell Aquila (submittedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Keywords
- fatty acid amide hydrolase, endocannabinoid system, anandamide, 2-arachidonoylglycerol, FAAH inhibitors, cannabinoid receptors, delta-9-tetrahydrocannabinol, membrane transporters, intracellular degradation, therapeutic target, central nervous system disorders
- MeSH terms
- Fatty Acid Amide Hydrolases, Amidohydrolases, Animals, Gene Expression Regulation, Humans, Models, Molecular, Receptors, Cannabinoid, Cannabinoid Receptor Modulators, Endocannabinoids
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review